Curis Lifesciences Limited IPO
Price Band
₹120 - ₹128
Total Issue
₹28 Cr
Bid Dates
07 Nov - 11 Nov
Subscription
74.39x
Listing Price
₹146 (14.06%)
Valuation
Market Cap
₹103.48 Cr
P/E Ratio
12.44x
P/B Ratio
4.68x
Curis Lifescience IPO Dates
Conflicting IPOs
IPOs with overlapping timeline
Business Overview
Curis Lifesciences is a pharmaceutical manufacturer engaged in producing a diverse range of formulations, including tablets, capsules, oral liquids, external preparations, and sterile ophthalmic ointments. The company operates across domestic and global markets under three business verticals — Loan License Manufacturing, Contract Manufacturing, and Direct Export/Own Brand Marketing. In loan license manufacturing, it undertakes production on behalf of clients who supply raw materials and formulations. Under contract manufacturing, Curis manages procurement and production, while clients handle branding and marketing. In direct exports, the company markets its own brands in Yemen and Kenya, handling end-to-end operations independently.
Curis Lifescience IPO Lot Size
| Category | Lots | Shares | Amount |
|---|---|---|---|
| Ind (Min) | 2 | 2,000 | ₹2,56,000 |
| Ind (Max) | 2 | 2,000 | ₹2,56,000 |
| S-HNI (Min) | 3 | 3,000 | ₹3,84,000 |
| S-HNI (Max) | 7 | 7,000 | ₹8,96,000 |
| B-HNI (Min) | 8 | 8,000 | ₹10,24,000 |
Curis Lifescience IPO Size
Objects of Issue
- Capital Expenditure towards Upgradation/Improvement of the existing Manufacturing Facilities.
- Capital Expenditure towards Construction of a Storage Facility
- Pre-payment/Repayment of outstanding Secured Loans
- Product Registrations in other countries
- Funding the Working Capital Requirements & General Corporate Purposes
- General Corporate Purposes
Curis Lifescience IPO Live Subscription
Updated as on 11-Nov-2025 19:00:50 hrs
| Category | Sub (x) | Offered | Bids |
|---|---|---|---|
| QIB | 96.17x | 4,09,000 | 3,93,35,000 |
| NII | 115.46x | 3,08,000 | 3,55,63,000 |
| bHNI | 143.20x | 2,05,333 | 2,94,04,000 |
| sHNI | 59.99x | 1,02,667 | 61,59,000 |
| Individual | 44.28x | 7,16,000 | 3,17,06,000 |
| Total | 74.39x | 14,33,000 | 10,66,04,000 |
Curis Lifescience IPO Details Live GMP
| Date | GMP (₹) | Est. Price |
|---|---|---|
| 11 Nov | ₹8 (6.3%) | ₹136 |
| 10 Nov | ₹8 (6.3%) | ₹136 |
| 09 Nov | ₹8 (6.3%) | ₹136 |
| 08 Nov | ₹8 (6.3%) | ₹136 |
| 07 Nov | ₹7.5 (5.9%) | ₹135.50 |
| 06 Nov | ₹7.5 (5.9%) | ₹135.50 |
Curis Lifescience IPO Peer Comparison
(Rs. in crores)
| Particulars | Curis Lifesciences | Sotac Pharma | PeeLincoln Pharma |
|---|---|---|---|
| Revenue from Ops (in Crs.) | 49.13 | 62.38 | 623.23 |
| PAT (In Crs.) | 6.11 | 4.77 | 82.35 |
| EPS - Basic | 10.29 | 4.32 | 41.11 |
| NAV per share | 27.34 | 47.99 | 335.34 |
| RONW | 37.62% | 9.00% | 12.27% |
| EBITDA | 19.41% | 12.31% | 16.29% |
| PAT Margin | 12.43% | 7.65% | 13.21% |
| Price to earning (PE) | 12.44 | 18.30 | 12.21 |
| Debt to Equity | 0.96 | 0.38 | - |
- All the information pertains to FY 2024-25
- The PE ratio is calculated using the Upper Price Band for the Issuer and the closing price as of October 28, 2025 for Peers
Curis Lifescience IPO Financial Performance
(Rs. in crores)
| Particulars | Jul-25 | Mar-25 | Mar-24 | Mar-23 |
|---|---|---|---|---|
| Revenue from Operations | 19.50 | 49.13 | 35.56 | 35.45 |
| Profit after Tax | 2.87 | 6.11 | 4.87 | 1.88 |
| Net Worth | 19.10 | 16.23 | 5.87 | 1.01 |
| Total Borrowing | 15.32 | 15.62 | 17.09 | 16.19 |
| Total Assets | 56.29 | 42.53 | 33.88 | 29.75 |
| NAV per share (in ₹) | 32.18 | 27.34 | 117.46 | 20.12 |
| EPS - Basic (in ₹) | 4.84 | 10.29 | 8.26 | 3.18 |
Key Performance Indicators (KPIs)
EBITDA
19.41%
PAT
12.43%
ROE
55.25%
ROCE
27.83%
Debt to Equity
0.96
- All Ratios are based on Mar 2024-25.
- PE, PB, and Post-Issue Market Capitalization are calculated based on the upper price band.
Promoter Holding
Promoter
92.68%
Public
7.32%
Management
Registrar & Lead Managers
Registrar
MUFG Intime India
Lead Managers (1)
Company Details
Name: Curis Lifesciences Limited
Address: PF-23, GIDC Sanand - II, Industrial Estate, Ahmedabad, Sanand, Gujarat-382110, India
Number: +91 99045 22543
Email: cs@curisls.com
Website: https://curisls.com/
Explore More IPOs
Discover other active and upcoming IPOs.
Live IPOs
View AllOpening Soon
View AllRecently Closed
View AllFrequently Asked Questions (FAQs)
What is Curis Lifescience IPO?
When will Curis Lifescience IPO open?
What is the GMP of Curis Lifescience IPO?
What is the lot size of Curis Lifescience IPO?
When is the allotment of Curis Lifescience IPO?
What is the listing date of Curis Lifescience IPO?
What is the subscription of Curis Lifescience IPO?
What is the price band of Curis Lifescience IPO?
How to check allotment status of Curis Lifescience IPO?
How to apply Curis Lifescience IPO in Zerodha?
- Go to Kite App → Tap on Bids → Tap on IPO
- Select the IPO → Tap on apply → Enter UPI ID
- Enter Qty and Price
- Submit the application
- Approve the UPI Mandate on your UPI app
How to apply Curis Lifescience IPO in Groww?
- Go to Groww App → Stocks Section → Select IPO option
- Select the IPO you want to apply
- Enter your bid details and price
- Enter UPI ID & submit
- Approve the UPI Mandate on your UPI app
How to apply Curis Lifescience IPO using ASBA?
- Log in to your bank's net banking portal.
- Navigate to the 'IPO' or 'ASBA' section.
- Select Curis Lifescience IPO from the list of available IPOs.
- Enter the required details: Bid quantity, Price, DP ID & Client ID, etc
- Submit the application.
- Money will remain blocked till the refund date
Delete Comment?
Are you sure you want to delete this comment? This action cannot be undone.
Discussion
Join the discussion!
Log In to CommentNo comments yet. Be the first to share your thoughts!